Predicting_VBG prostate_NN cancer_NN recurrence_NN via_IN maximizing_VBG the_DT concordance_NN index_NN
In_IN order_NN to_TO effectively_RB use_VB machine_NN learning_NN algorithms_NNS ,_, e.g._FW ,_, neural_JJ networks_NNS ,_, for_IN the_DT analysis_NN of_IN survival_NN data_NNS ,_, the_DT correct_JJ treatment_NN of_IN censored_VBN data_NNS is_VBZ crucial_JJ ._.
The_DT concordance_NN index_NN -LRB-_-LRB- CI_NN -RRB-_-RRB- is_VBZ a_DT typical_JJ metric_NN for_IN quantifying_VBG the_DT predictive_JJ ability_NN of_IN a_DT survival_NN model_NN ._.
We_PRP propose_VBP a_DT new_JJ algorithm_NN that_WDT directly_RB uses_VBZ the_DT CI_NN as_IN the_DT objective_JJ function_NN to_TO train_VB a_DT model_NN ,_, which_WDT predicts_VBZ whether_IN an_DT event_NN will_MD eventually_RB occur_VB or_CC not_RB ._.
Directly_RB optimizing_VBG the_DT CI_NN allows_VBZ the_DT model_NN to_TO make_VB complete_JJ use_NN of_IN the_DT information_NN from_IN both_CC censored_VBN and_CC non-censored_JJ observations_NNS ._.
In_IN particular_JJ ,_, we_PRP approximate_JJ the_DT CI_NN via_IN a_DT differentiable_JJ function_NN so_IN that_IN gradient-based_JJ methods_NNS can_MD be_VB used_VBN to_TO train_VB the_DT model_NN ._.
We_PRP applied_VBD the_DT new_JJ algorithm_NN to_TO predict_VB the_DT eventual_JJ recurrence_NN of_IN prostate_NN cancer_NN following_VBG radical_JJ prostatectomy_NN ._.
Compared_VBN with_IN the_DT traditional_JJ Cox_NN proportional_JJ hazards_NNS model_NN and_CC several_JJ other_JJ algorithms_NNS based_VBN on_IN neural_JJ networks_NNS and_CC support_NN vector_NN machines_NNS ,_, our_PRP$ algorithm_NN achieves_VBZ a_DT significant_JJ improvement_NN in_IN being_VBG able_JJ to_TO identify_VB high-risk_JJ and_CC low-risk_JJ groups_NNS of_IN patients_NNS ._.
researchers_NNS have_VBP used_VBN differentiable_JJ approximation_NN to_TO the_DT concordance_NN index_NN -LRB-_-LRB- a_DT common_JJ survival_NN model_NN quality_NN metric_NN -RRB-_-RRB- directly_RB as_IN the_DT objective_JJ function_NN for_IN training_NN various_JJ classification_NN algorithms_NNS =_JJ -_: =[_NN 64_CD -RRB-_-RRB- -_: =_SYM -_: ._.
Using_VBG this_DT metric_NN with_IN a_DT neural_JJ network_NN model_NN ,_, they_PRP demonstrate_VBP improvement_NN in_IN separating_VBG low-risk_JJ and_CC high-risk_JJ groups_NNS of_IN patients_NNS ._.
Other_JJ researchers_NNS have_VBP focused_VBN their_PRP$ research_NN on_IN simple_JJ models_NNS de_IN
city_NN of_IN the_DT decision_NN rules_NNS obtained_VBN on_IN one_CD set_NN and_CC tested_VBN on_IN another_DT set_NN ._.
For_IN comparison_NN we_PRP use_VBP SVRc_JJ TM_NN method_NN which_WDT uses_VBZ some_DT adjustment_NN of_IN the_DT support_NN vector_NN regression_NN method_NN for_IN the_DT censored_VBN data_NN =_JJ -_: =[_NN 17_CD -RRB-_-RRB- -_: =_SYM -_: ._.
Comparing_VBG Sensitivity_NN and_CC Specificity_NN of_IN Live_NNP Logic_NNP TM_NNP and_CC SVRc_FW TM_FW Datasets_FW Sensitivity_NN Specificity_NN Training_NN Testing_VBG LL_NN SVRc_FW TM_FW LL_FW SVRc_FW TM_NN Set_NN 1_CD Set_NN 2_CD 0.79_CD 0.5_CD 0.77_CD 0.87_CD Set_NN 2_CD Set_NN 2_CD 0.8_CD 0.65_CD 0.66_CD 0_CD ._.
nally_RB developed_VBN for_IN classification_NN ,_, their_PRP$ main_JJ advantage_NN being_VBG their_PRP$ ability_NN to_TO handle_VB high_JJ dimensional_JJ data_NNS ._.
Support_NN vector_NN machines_NNS were_VBD extended_VBN for_IN regression_NN -LRB-_-LRB- 16_CD -RRB-_-RRB- ._.
Our_PRP$ company_NN has_VBZ patented_VBN SVRc_JJ ™_NN =_JJ -_: =[_NN 17_CD -RRB-_-RRB- -_: =_JJ -_: ,_, assupport_NN vector_NN regression_NN algorithm_NN that_WDT is_VBZ applied_VBN to_TO survival_NN data_NNS ._.
The_DT output_NN of_IN SVRc_FW ™_FW is_VBZ also_RB predicted_VBN time_NN ._.
For_IN censored_VBN patients_NNS ,_, SVRc_FW ™_FW assigns_VBZ less_JJR of_IN a_DT penalty_NN to_TO over-predicted_JJ times_NNS tha_NN
posed_VBN by_IN one_CD of_IN us_PRP -LRB-_-LRB- 19_CD -RRB-_-RRB- to_TO directly_RB optimize_VB the_DT AUC_NN during_IN training_NN and_CC thus_RB to_TO improve_VB classifier_NN performance_NN ._.
In_IN -LRB-_-LRB- 19_CD -RRB-_-RRB- ,_, several_JJ alternative_JJ approximations_NNS 1_CD We_PRP use_VBP the_DT limited_JJ memory_NN BFGS_NN method_NN in_IN =_JJ -_: =[_NN 16_CD -RRB-_-RRB- -_: =_SYM -_: ._.
sto_NN Eq_NN ._.
2_CD are_VBP discussed_VBN ._.
The_DT intuitive_JJ choice_NN is_VBZ the_DT sigmoid_JJ function_NN S_NN -LRB-_-LRB- ˆti_NN ,_, ˆtj_NN -RRB-_-RRB- 1_CD =_JJ 1_CD +_CC e_SYM −_FW β_FW -LRB-_-LRB- ,_, -LRB-_-LRB- 4_CD -RRB-_-RRB- ˆt_FW i_FW −_FW tˆ_FW j_NN -RRB-_-RRB- where_WRB β_NN -RRB-_-RRB- 0_CD ._.
However_RB ,_, this_DT is_VBZ found_VBN to_TO be_VB less_RBR effective_JJ than_IN the_DT following_JJ function_NN
s_NN nondifferentiable_JJ and_CC can_MD not_RB be_VB optimized_VBN by_IN gradient-based_JJ methods_NNS ._.
2.2_CD Maximizing_VBG the_DT concordance_NN index_NN A_NN differentaible_JJ approximation_NN to_TO the_DT step_NN function_NN in_IN Eq_NN ._.
2_CD has_VBZ been_VBN proposed_VBN by_IN one_CD of_IN us_PRP =_JJ -_: =[_NN 19_CD -RRB-_-RRB- -_: =_SYM -_: to_TO directly_RB optimize_VB the_DT AUC_NN during_IN training_NN and_CC thus_RB to_TO improve_VB classifier_NN performance_NN ._.
In_IN -LRB-_-LRB- 19_CD -RRB-_-RRB- ,_, several_JJ alternative_JJ approximations_NNS 1_CD We_PRP use_VBP the_DT limited_JJ memory_NN BFGS_NN method_NN in_IN -LRB-_-LRB- 16_CD -RRB-_-RRB- ._.
sto_NN Eq_NN ._.
2_CD are_VBP disc_NN
n_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- ,_, the_DT authors_NNS construct_VBP the_DT survival_NN curve_NN by_IN a_DT hazard_NN function_NN modeled_VBN by_IN a_DT neural_JJ network_NN ,_, for_IN which_WDT the_DT ith_NN output_NN is_VBZ the_DT estimated_VBN hazard_NN at_IN the_DT discretized_JJ time_NN interval_JJ i._NNP Biganzoli_NNP et_FW al._FW =_SYM -_: =[_NN 1_CD -RRB-_-RRB- -_: =_SYM -_: used_VBD the_DT discretized_JJ time_NN interval_NN as_IN an_DT additional_JJ input_NN to_TO a_DT neural_JJ network_NN to_TO model_VB the_DT survival_NN probability_NN ._.
Other_JJ authors_NNS used_VBD several_JJ separately_RB trained_JJ networks_NNS ,_, each_DT used_VBN to_TO model_VB the_DT hazard_NN
the_DT scores_NNS ._.
3_CD However_RB ,_, for_IN both_CC NNae_NN and_CC SVRc_NN ,_, the_DT high-risk_JJ patients_NNS are_VBP in_IN the_DT lowest_JJS quartile_NN of_IN the_DT scores_NNS ,_, and_CC the_DT low-risk_JJ patients_NNS fall_VBP in_IN the_DT highest_JJS quartile_NN of_IN the_DT scores_NNS ._.
The_DT logrank_JJ test_NN =_JJ -_: =[_NN 12_CD -RRB-_-RRB- -_: =_JJ -_: is_VBZ conducted_VBN for_IN each_DT pair_NN of_IN survival_NN curves_NNS of_IN high-risk_JJ and_CC low-risk_JJ groups_NNS within_IN each_DT model_NN ._.
The_DT p_NN value_NN indicates_VBZ how_WRB significant_JJ the_DT model_NN can_MD distinguish_VB high-risk_JJ and_CC low-risk_JJ patient_NN groups_NNS
me_PRP and_CC censoring_VBG ,_, but_CC it_PRP still_RB fails_VBZ to_TO make_VB complete_JJ use_NN of_IN all_PDT the_DT available_JJ information_NN ._.
For_IN instance_NN ,_, it_PRP treats_VBZ two_CD recurred_JJ patients_NNS as_IN the_DT same_JJ regardless_RB of_IN their_PRP$ survival_NN time_NN ._.
deSilva_FW et_FW al._FW =_SYM -_: =[_NN 5_CD -RRB-_-RRB- -_: =_SYM -_: tried_VBD to_TO train_VB a_DT neural_JJ network_NN by_IN incorporating_VBG both_CC follow-up_JJ time_NN and_CC censorship_NN into_IN a_DT modified_VBN objective_NN function_NN ._.
The_DT model_NN regresses_VBZ over_IN the_DT survival_NN time_NN ,_, but_CC the_DT error_NN term_NN for_IN censored_VBN sam_NN
model_NN will_MD recur_VB within_IN a_DT shorter_JJR time_NN than_IN a_DT patient_NN with_IN a_DT lower_JJR score_NN ._.
The_DT CI_NN is_VBZ tightly_RB associated_VBN with_IN the_DT area_NN under_IN the_DT ROC_NN curve_NN -LRB-_-LRB- AUC_NN -RRB-_-RRB- ,_, which_WDT is_VBZ a_DT common_JJ performance_NN metric_NN for_IN classification_NN =_JJ -_: =[_NN 7_CD -RRB-_-RRB- -_: =_SYM -_: ._.
The_DT AUC_NN is_VBZ equivalent_JJ to_TO the_DT WilcoxonMann-Whitney_NNP statistic_NN in_IN the_DT form_NN U_NN =_JJ -LRB-_-LRB- i_LS ,_, j_NN -RRB-_-RRB- ∈_NN Θ_NN I_CD -LRB-_-LRB- ˆsi_NN ,_, ˆsj_NN -RRB-_-RRB- ,_, -LRB-_-LRB- 3_LS -RRB-_-RRB- |_FW Θ_FW |_FW where_WRB ˆsi_NN and_CC ˆsj_NN are_VBP the_DT classifier_JJR outputs_NNS for_IN a_DT positive_JJ sample_NN i_FW and_CC a_DT negative_JJ sampl_NN
t_NN algorithm_NN we_PRP compared_VBD NNci_NN with_IN is_VBZ the_DT Cox_NNP proportional_JJ hazard_NN model_NN ._.
The_DT Cox_NNP model_NN outputs_VBZ a_DT prognostic_JJ hazard_NN score_NN ,_, which_WDT is_VBZ a_DT function_NN of_IN a_DT linear_JJ combination_NN of_IN the_DT covariates_NNS -LRB-_-LRB- input_NN features_NNS -RRB-_-RRB- =_JJ -_: =[_NN 15_CD -RRB-_-RRB- -_: =_SYM -_: ._.
The_DT higher_JJR the_DT score_NN is_VBZ ,_, the_DT more_JJR risk_NN the_DT model_NN predicts_VBZ the_DT patient_NN would_MD have_VB ._.
4.2_CD Results_NNS The_DT empirical_JJ results_NNS are_VBP based_VBN on_IN leave-one-out_JJ cross_NN validation_NN ._.
For_IN all_PDT the_DT algorithms_NNS ,_, we_PRP conducted_VBD
ment_NN ._.
A_DT number_NN of_IN prostate_NN cancer_NN nomograms_NNS which_WDT combine_VBP clinical_JJ and\/or_CC pathologic_JJ factors_NNS to_TO predict_VB an_DT individual_JJ patients_NNS probability_NN of_IN disease_NN recurrence_NN or_CC survival_NN have_VBP been_VBN published_VBN ,_, e.g._FW ,_, =_JJ -_: =[_NN 14_CD -RRB-_-RRB- -_: =_JJ -_: -LRB-_-LRB- 6_CD -RRB-_-RRB- -LRB-_-LRB- 11_CD -RRB-_-RRB- ._.
The_DT postoperative_JJ nomogram_NN developed_VBN by_IN Kattan_NNP et_FW al._FW -LRB-_-LRB- 14_CD -RRB-_-RRB- is_VBZ widely_RB used_VBN by_IN clinicians_NNS and_CC allows_VBZ a_DT prediction_NN of_IN the_DT probability_NN of_IN disease_NN recurrence_NN for_IN patients_NNS who_WP have_VBP received_VBN radic_JJ
ffectively_RB use_VB machine_NN learning_NN algorithms_NNS in_IN this_DT scenario_NN ,_, the_DT correct_JJ treatment_NN of_IN censored_VBN data_NNS is_VBZ crucial_JJ ._.
Simply_RB omitting_VBG the_DT censored_VBN observations_NNS -LRB-_-LRB- 3_CD -RRB-_-RRB- or_CC treating_VBG them_PRP as_IN non-recurring_JJ samples_NNS =_JJ -_: =[_NN 18_CD -RRB-_-RRB- -_: =_SYM -_: both_DT obviously_RB bias_NN the_DT resulting_VBG model_NN and_CC should_MD be_VB avoided_VBN ._.
Zupan_NNP et_FW al._FW -LRB-_-LRB- 20_CD -RRB-_-RRB- used_VBN Kaplan-Meier_NNP estimates_NNS of_IN event_NN probability_NN as_IN target_NN values_NNS during_IN training_NN for_IN the_DT patients_NNS who_WP had_VBD short_JJ follo_NN
l_NN classification_NN problem_NN ._.
Still_RB ,_, in_IN order_NN to_TO effectively_RB use_VB machine_NN learning_NN algorithms_NNS in_IN this_DT scenario_NN ,_, the_DT correct_JJ treatment_NN of_IN censored_VBN data_NNS is_VBZ crucial_JJ ._.
Simply_RB omitting_VBG the_DT censored_VBN observations_NNS =_JJ -_: =[_NN 3_CD -RRB-_-RRB- -_: =_JJ -_: or_CC treating_VBG them_PRP as_IN non-recurring_JJ samples_NNS -LRB-_-LRB- 18_CD -RRB-_-RRB- both_CC obviously_RB bias_NN the_DT resulting_VBG model_NN and_CC should_MD be_VB avoided_VBN ._.
Zupan_NNP et_FW al._FW -LRB-_-LRB- 20_CD -RRB-_-RRB- used_VBN Kaplan-Meier_NNP estimates_NNS of_IN event_NN probability_NN as_IN target_NN values_NNS durin_VBP
ty_NN of_IN the_DT event_NN occurring_VBG within_IN a_DT specific_JJ time_NN ._.
However_RB ,_, in_IN general_JJ ,_, the_DT reliability_NN of_IN the_DT Cox_NNP model_NN deteriorates_VBZ if_IN the_DT number_NN of_IN features_NNS is_VBZ greater_JJR than_IN the_DT number_NN of_IN events_NNS divided_VBN by_IN 10_CD or_CC 20_CD =_JJ -_: =[_NN 9_CD -RRB-_-RRB- -_: =_SYM -_: ._.
In_IN our_PRP$ application_NN ,_, it_PRP is_VBZ expensive_JJ and_CC difficult_JJ to_TO collect_VB the_DT patient_NN data_NNS ,_, and_CC the_DT data_NNS set_NN consists_VBZ of_IN only_RB 130_CD patients_NNS ,_, each_DT of_IN which_WDT is_VBZ represented_VBN by_IN a_DT vector_NN of_IN 25_CD features_NNS ._.
We_PRP have_VBP seen_VBN t_NN
itional_JJ input_NN to_TO a_DT neural_JJ network_NN to_TO model_VB the_DT survival_NN probability_NN ._.
Other_JJ authors_NNS used_VBD several_JJ separately_RB trained_JJ networks_NNS ,_, each_DT used_VBN to_TO model_VB the_DT hazard_NN function_NN at_IN a_DT different_JJ time_NN interval_NN ,_, e.g._FW ,_, =_JJ -_: =[_NN 17_CD -RRB-_-RRB- -_: =_SYM -_: ._.
Neural_JJ networks_NNS have_VBP been_VBN shown_VBN to_TO be_VB able_JJ to_TO outperform_VB traditional_JJ statistical_JJ models_NNS ,_, probably_RB due_JJ to_TO neural_JJ networks_NNS '_POS capacity_NN to_TO model_NN nonlinearities_NNS -LRB-_-LRB- 13_CD -RRB-_-RRB- ._.
However_RB ,_, these_DT algorithms_NNS require_VBP a_DT l_NN
een_NN applied_VBN to_TO survival_NN analysis_NN ._.
There_EX are_VBP two_CD types_NNS of_IN approaches_NNS to_TO using_VBG neural_JJ networks_NNS for_IN survival_NN data_NNS ._.
The_DT first_JJ type_NN models_NNS the_DT hazard_NN or_CC survival_NN function_NN as_IN a_DT neural_JJ network_NN structure_NN ._.
In_IN =_JJ -_: =[_NN 2_CD -RRB-_-RRB- -_: =_JJ -_: ,_, the_DT authors_NNS construct_VBP the_DT survival_NN curve_NN by_IN a_DT hazard_NN function_NN modeled_VBN by_IN a_DT neural_JJ network_NN ,_, for_IN which_WDT the_DT ith_NN output_NN is_VBZ the_DT estimated_VBN hazard_NN at_IN the_DT discretized_JJ time_NN interval_JJ i._NNP Biganzoli_NNP et_FW al._FW -LRB-_-LRB- 1_LS -RRB-_-RRB- u_NN
only_RB one_CD -RRB-_-RRB- and_CC examining_VBG complex_JJ interactions_NNS which_WDT results_VBZ in_IN a_DT superior_JJ output_NN of_IN data_NNS and_CC information_NN ,_, thereby_RB enhancing_VBG our_PRP$ understanding_NN of_IN biological_JJ function_NN and_CC chemico-biological_JJ interactions_NNS =_JJ -_: =[_NN 4_CD -RRB-_-RRB- -_: =_SYM -_: ._.
The_DT number_NN of_IN features_NNS generated_VBN by_IN these_DT technologies_NNS can_MD be_VB larger_JJR than_IN standard_JJ survival_NN methods_NNS can_MD handle_VB ._.
Thus_RB ,_, the_DT underlying_JJ hypothesis_NN of_IN this_DT study_NN is_VBZ that_IN an_DT improved_VBN predictive_JJ model_NN for_IN
A_DT number_NN of_IN prostate_NN cancer_NN nomograms_NNS which_WDT combine_VBP clinical_JJ and\/or_CC pathologic_JJ factors_NNS to_TO predict_VB an_DT individual_JJ patients_NNS probability_NN of_IN disease_NN recurrence_NN or_CC survival_NN have_VBP been_VBN published_VBN ,_, e.g._FW ,_, -LRB-_-LRB- 14_CD -RRB-_-RRB- =_JJ -_: =[_NN 6_CD -RRB-_-RRB- -_: =_JJ -_: -LRB-_-LRB- 11_CD -RRB-_-RRB- ._.
The_DT postoperative_JJ nomogram_NN developed_VBN by_IN Kattan_NNP et_FW al._FW -LRB-_-LRB- 14_CD -RRB-_-RRB- is_VBZ widely_RB used_VBN by_IN clinicians_NNS and_CC allows_VBZ a_DT prediction_NN of_IN the_DT probability_NN of_IN disease_NN recurrence_NN for_IN patients_NNS who_WP have_VBP received_VBN radical_JJ p_NN
ected_VBN ,_, and_CC will_MD necessitate_VB restaging_VBG the_DT cancer_NN ,_, as_RB well_RB as_IN a_DT discussion_NN of_IN possible_JJ salvage_NN therapies_NNS with_IN the_DT patient_NN including_VBG radiation_NN or_CC hormonal_JJ therapy_NN ,_, experimental_JJ protocols_NNS or_CC observation_NN =_JJ -_: =[_NN 8_CD -RRB-_-RRB- -_: =_SYM -_: ._.
Thus_RB ,_, the_DT ability_NN to_TO predict_VB which_WDT patients_NNS will_MD have_VB a_DT BCR_NN would_MD be_VB very_RB important_JJ to_TO urologists_NNS and_CC oncologists_NNS in_IN managing_VBG the_DT course_NN of_IN future_JJ treatment_NN ._.
A_DT number_NN of_IN prostate_NN cancer_NN nomograms_NNS wh_VBP
on_IN at_IN a_DT different_JJ time_NN interval_NN ,_, e.g._FW ,_, -LRB-_-LRB- 17_CD -RRB-_-RRB- ._.
Neural_JJ networks_NNS have_VBP been_VBN shown_VBN to_TO be_VB able_JJ to_TO outperform_VB traditional_JJ statistical_JJ models_NNS ,_, probably_RB due_JJ to_TO neural_JJ networks_NNS '_POS capacity_NN to_TO model_VB nonlinearities_NNS =_JJ -_: =[_NN 13_CD -RRB-_-RRB- -_: =_SYM -_: ._.
However_RB ,_, these_DT algorithms_NNS require_VBP a_DT large_JJ number_NN of_IN samples_NNS in_IN the_DT training_NN set_VBN in_IN order_NN to_TO be_VB successful_JJ -LRB-_-LRB- 2_CD -RRB-_-RRB- ._.
Different_JJ from_IN the_DT traditional_JJ survival_NN analysis_NN ,_, some_DT applications_NNS '_POS primary_JJ goal_NN is_VBZ to_TO
objective_JJ function_NN to_TO train_VB a_DT model_NN ,_, which_WDT predicts_VBZ whether_IN an_DT event_NN will_MD eventually_RB occur_VB or_CC not_RB ._.
The_DT concordance_NN index_NN is_VBZ a_DT typical_JJ metric_NN for_IN quantifying_VBG the_DT predictive_JJ ability_NN of_IN a_DT survival_NN model_NN =_JJ -_: =[_NN 10_CD -RRB-_-RRB- -_: =_SYM -_: ._.
In_IN our_PRP$ application_NN ,_, the_DT CI_NN estimates_VBZ the_DT probability_NN that_IN ,_, of_IN a_DT pair_NN of_IN randomly_RB chosen_VBN comparable_JJ patients_NNS ,_, the_DT patient_NN with_IN the_DT higher_JJR prognostic_JJ score_NN from_IN the_DT model_NN will_MD recur_VB within_IN a_DT shorter_JJR t_NN
t_NN of_IN censored_VBN data_NNS is_VBZ crucial_JJ ._.
Simply_RB omitting_VBG the_DT censored_VBN observations_NNS -LRB-_-LRB- 3_CD -RRB-_-RRB- or_CC treating_VBG them_PRP as_IN non-recurring_JJ samples_NNS -LRB-_-LRB- 18_CD -RRB-_-RRB- both_CC obviously_RB bias_NN the_DT resulting_VBG model_NN and_CC should_MD be_VB avoided_VBN ._.
Zupan_NNP et_FW al._FW =_SYM -_: =[_NN 20_CD -RRB-_-RRB- -_: =_SYM -_: used_VBN Kaplan-Meier_NNP estimates_NNS of_IN event_NN probability_NN as_IN target_NN values_NNS during_IN training_NN for_IN the_DT patients_NNS who_WP had_VBD short_JJ follow-up_JJ times_NNS and_CC did_VBD not_RB have_VB an_DT occurred_VBN event_NN ._.
This_DT algorithm_NN does_VBZ take_VB into_IN acco_NN
umber_NN of_IN prostate_NN cancer_NN nomograms_NNS which_WDT combine_VBP clinical_JJ and\/or_CC pathologic_JJ factors_NNS to_TO predict_VB an_DT individual_JJ patients_NNS probability_NN of_IN disease_NN recurrence_NN or_CC survival_NN have_VBP been_VBN published_VBN ,_, e.g._FW ,_, -LRB-_-LRB- 14_CD -RRB-_-RRB- -LRB-_-LRB- 6_CD -RRB-_-RRB- =_JJ -_: =[_NN 11_CD -RRB-_-RRB- -_: =_SYM -_: ._.
The_DT postoperative_JJ nomogram_NN developed_VBN by_IN Kattan_NNP et_FW al._FW -LRB-_-LRB- 14_CD -RRB-_-RRB- is_VBZ widely_RB used_VBN by_IN clinicians_NNS and_CC allows_VBZ a_DT prediction_NN of_IN the_DT probability_NN of_IN disease_NN recurrence_NN for_IN patients_NNS who_WP have_VBP received_VBN radical_JJ prosta_NN
